PTGS2 and neoplasm: Cyclooxygenase-2 represents another critical inflammatory mediator implicated in cancer pathogenesis, catalyzing the conversion of arachidonic acid to prostaglandins that promote inflammation, cell proliferation, angiogenesis, and immune suppression within the tumor microenvironment.